Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2024-2034
Global Gene Therapy Medicinal Products (GTMP) Scope and Market Size
Gene Therapy Medicinal Products (GTMP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy Medicinal Products (GTMP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Medicinal Products (GTMP) Market Perspective (2016-2027)
2.2 Gene Therapy Medicinal Products (GTMP) Growth Trends by Regions
2.2.1 Gene Therapy Medicinal Products (GTMP) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy Medicinal Products (GTMP) Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy Medicinal Products (GTMP) Industry Dynamic
2.3.1 Gene Therapy Medicinal Products (GTMP) Market Trends
2.3.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
2.3.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
2.3.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue
3.1.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Medicinal Products (GTMP) Revenue
3.4 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio
3.4.1 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicinal Products (GTMP) Revenue in 2020
3.5 Gene Therapy Medicinal Products (GTMP) Key Players Head office and Area Served
3.6 Key Players Gene Therapy Medicinal Products (GTMP) Product Solution and Service
3.7 Date of Enter into Gene Therapy Medicinal Products (GTMP) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2022-2027)
5 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
6.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type
6.2.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application
6.3.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
6.4 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country
6.4.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type
7.2.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application
7.3.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
7.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country
7.4.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
9.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type
9.2.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application
9.3.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country
9.4.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2016-2021)
11.8.5 Advantagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details